Genomic classification of intrapulmonary metastasis and multiple primary lung cancer

Jeongsoo Won; Yeon Seung Chung; Se-Young Jo; Jiho Park; Hyo Sup Shim; Sangwoo Kim

doi:10.1002/ctm2.70463

Clinical and Translational Medicine ›› 2025, Vol. 15 ›› Issue (9) : e70463 DOI: 10.1002/ctm2.70463

LETTER TO THE JOURNAL

Genomic classification of intrapulmonary metastasis and multiple primary lung cancer

Author information +

History +

PDF

Cite this article

Download citation ▾

Jeongsoo Won, Yeon Seung Chung, Se-Young Jo, Jiho Park, Hyo Sup Shim, Sangwoo Kim. Genomic classification of intrapulmonary metastasis and multiple primary lung cancer. Clinical and Translational Medicine, 2025, 15(9): e70463 DOI:10.1002/ctm2.70463

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Arai J, Tsuchiya T, Oikawa M, et al. Clinical and molecular analysis of synchronous double lung cancers. Lung Cancer. 2012; 77(2): 281-287.

[2]	Amin MB, Edge SB, Greene FL, et al. AJCC Cancer Staging Manual. Springer International Publishing; 2018.

[3]	National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®): non-small cell lung cancer (version 6.2025). Accessed 07/02, 2025. https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf

[4]

Chou TY, Dacic S, Wistuba I, et al. Differentiating separate primary lung adenocarcinomas from intrapulmonary metastases with emphasis on pathological and molecular considerations: recommendations from the International Association for the Study of Lung Cancer Pathology Committee. J Thorac Oncol. 2025; 20(3): 311-330.

[5]	Martini N, Melamed MR. Multiple primary lung cancers. J Thorac Cardiovasc Surg. 1975; 70(4): 606-612.

[6]	Girard N, Deshpande C, Lau C, et al. Comprehensive histologic assessment helps to differentiate multiple lung primary nonsmall cell carcinomas from metastases. Am J Surg Pathol. 2009; 33(12): 1752-1764.

[7]	Chang YL, Wu CT, Lin SC, Hsiao CF, Jou YS, Lee YC. Clonality and prognostic implications of p53 and epidermal growth factor receptor somatic aberrations in multiple primary lung cancers. Clin Cancer Res. 2007; 13(1): 52-58.

[8]	Loukeri AA, Kampolis CF, Ntokou A, Tsoukalas G, Syrigos K. Metachronous and synchronous primary lung cancers: diagnostic aspects, surgical treatment, and prognosis. Clin Lung Cancer. 2015; 16(1): 15-23.

RIGHTS & PERMISSIONS

2025 The Author(s). Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.